Ruta Rao to Breast Neoplasms
This is a "connection" page, showing publications Ruta Rao has written about Breast Neoplasms.
Connection Strength
1.148
-
Adjuvant endocrine therapy for breast cancer. Oncology (Williston Park). 2012 Jun; 26(6):541-7, 550, 552 passim.
Score: 0.292
-
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group. Med Oncol. 2011 Dec; 28 Suppl 1:S39-47.
Score: 0.260
-
ASO Author Reflections: Applying the Counterfactual Approach to Disparities in Breast Cancer Treatment Delays. Ann Surg Oncol. 2022 11; 29(12):7659-7660.
Score: 0.147
-
Factors Mediating Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer. Ann Surg Oncol. 2022 Nov; 29(12):7652-7658.
Score: 0.146
-
100 Disruptive Publications in Breast Cancer Research. Asian Pac J Cancer Prev. 2021 Aug 01; 22(8):2385-2389.
Score: 0.138
-
Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy. Brachytherapy. 2009 Jul-Sep; 8(3):331-4.
Score: 0.059
-
Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts. J Hematol Oncol. 2008 Aug 14; 1:12.
Score: 0.056
-
Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer. Genes Chromosomes Cancer. 2007 Apr; 46(4):397-405.
Score: 0.051